Temoside 250 mg (Temozolomide IP) is an oral chemotherapy capsule manufactured by Cipla. It is primarily prescribed to treat aggressive brain cancers, such as glioblastoma multifo…
Temoside 250 mg (Temozolomide IP) is an oral chemotherapy capsule manufactured by Cipla. It is primarily prescribed to treat aggressive brain cancers, such as glioblastoma multiforme and anaplastic astrocytoma. It functions as an alkylating agent that targets and damages cancer cell DNA, hindering their growth and replication.
liketo,usa.uk.china.southkorea.russia.japan.singapore
Strength 250 mg
Brand Temoside 250
Capsules per Pack 5 Capsules
Form Capsule
Usage Cancer Care, Brain Tumor
Manufacturer Cipla
Prescription/Non prescription Prescription
Country of Origin Made in India
Pack Type Bottle
Brand Name Temoside
Product Form Capsules
Pack Size 1*5 Capsules
Composition Temozolomide Capsules IP
Dose 250mg/100mg/20mg
Minimum order quantity: 50 Bottle
Composition details not available.
We offer reliable delivery across India and international markets. Domestic orders typically arrive within 5–7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity and quality.
